Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overall Survival, OS”

Showing 12 of 0 results

Not applicableStudy completedNCT02450812
What this trial is testing

Non-interventional Study With Ra-223 Dichloride Assessing Overall Survival and Effectiveness Predictors for mCRPC Patients in a Real Life Setting in Germany

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Bayer 86
Not applicableEnrolling By InvitationNCT04491721
What this trial is testing

Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Chinese Academy of Medical Sciences 407
Testing effectiveness (Phase 2)Study completedNCT01581307
What this trial is testing

Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets

Who this might be right for
Liver CancerPancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 9
Large-scale testing (Phase 3)Looking for participantsNCT02416388
What this trial is testing

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

Who this might be right for
Acute Myeloid Leukemia (AML)
University Hospital, Angers 3,100
Not applicableStudy completedNCT05520138
What this trial is testing

Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Pfizer 5,506
Testing effectiveness (Phase 2)Study completedNCT01392183
What this trial is testing

Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Kidney Cancer
M.D. Anderson Cancer Center 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT02586857
What this trial is testing

A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Acerta Pharma BV 24
Testing effectiveness (Phase 2)Study completedNCT04393220
What this trial is testing

Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma

Who this might be right for
Progress Free Survival (PFS) and Overall Survival (OS)
Fuda Cancer Hospital, Guangzhou 60
Early research (Phase 1)WithdrawnNCT05375825
What this trial is testing

Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

Who this might be right for
Malignant Pleural Mesotheliomas (Mpm)Malignant Pleural Effusions (Mpe)Epithelial Tumors, Malignant+2 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT06271369
What this trial is testing

Real-World HRU and Costs in DLBCL Pts With Tisa-cel and Axi-cel, a Medicare Study.

Who this might be right for
Diffuse Large B-cell Lymphoma
Novartis Pharmaceuticals 613
Testing effectiveness (Phase 2)UnknownNCT04699214
What this trial is testing

Endostar Combined With AI Regimen Compared With AI in Adjuvant Treatment

Who this might be right for
Other Disorders of Soft Tissues
Yong Chen 210
Testing effectiveness (Phase 2)Study completedNCT04815720
What this trial is testing

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Vaccinex Inc. 49

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation